Alterity Therapeutics Limited (ATHE) Financials

ATHE Assets vs Liabilities
DateAssetsLiabilities
June 30, 2024 12.8 million 3.6 million
March 31, 2024 8.2 million 2.3 million
Dec. 31, 2023 15.1 million 3.1 million
Sept. 30, 2023 ? ?

ATHE Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
June 30, 2024 -5.4 million 380177
March 31, 2024 -1.7 million ?
Dec. 31, 2023 -3.3 million 212761
Sept. 30, 2023 350323 ?

ATHE Net Income

No data available :(

ATHE Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
June 30, 2024 8.4 million 34645 106142
March 31, 2024 5.4 million - -
Dec. 31, 2023 8.4 million 52122 174138
Sept. 30, 2023 - - -

ATHE Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
June 30, 2024 4.2 billion
March 31, 2024 3.1 billion
Dec. 31, 2023 1.7 billion
Sept. 30, 2023 ?

ATHE Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
June 30, 2024 185 8.2 million 1.8 million -3340
March 31, 2024 - 2.6 million 576424 1065
Dec. 31, 2023 1362 4.3 million 1.4 million 12523
Sept. 30, 2023 2571 - - -

ATHE Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
June 30, 2024 1.4 million 49126
March 31, 2024 451223 24990
Dec. 31, 2023 1.3 million 50359
Sept. 30, 2023 - -

ATHE

Price: $4.31

52 week price:
2.66
7.00

Earnings Per Share: -0.59 USD

P/E Ratio: -5.97

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Country: Australia

Volume: 8900

Market Capitalization: 36.7 million

Links: